Search
Caris Life Sciences, Backed by Sixth Street, Aims for $5.3 Billion Valuation in US IPO
3 week ago /
Read about 0 minute
Author：小编
Caris Life Sciences, a leading cancer diagnostics company, announced on Monday its intention to seek a valuation of up to $5.35 billion in its upcoming initial public offering (IPO) in the United States. The Texas-headquartered firm plans to offer 23.5 million shares, priced between $16 and $18 each, with the goal of raising approximately $424 million.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
